CHAMPIONS ONCOLOGY, INC. (CSBR)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 04-30. Amounts in USD.

Revenue TTM

0 3.5M 7M 10.5M Q1 '17: 3.3M Q2 '17: 3.2M Q3 '17: 3.1M Q4 '17: 3.3M Q1 '18: 3M Q2 '18: 2.9M Q3 '18: 2.8M Q4 '18: 2.6M Q1 '19: 2.4M Q2 '19: 2.6M Q3 '19: 2.8M Q4 '19: 3.1M Q1 '20: 3.4M Q2 '20: 3.6M Q3 '20: 4.1M Q4 '20: 4.2M Q1 '21: 4.6M Q2 '21: 5M Q3 '21: 5.1M Q4 '21: 5.5M Q1 '22: 5.9M Q2 '22: 6.2M Q3 '22: 6.2M Q4 '22: 6.4M Q1 '23: 6.5M Q2 '23: 6.6M Q3 '23: 6.8M Q4 '23: 7M Q1 '24: 7M Q2 '24: 7.1M Q3 '24: 7.1M Q4 '24: 7.1M Q1 '25: 7M Q2 '25: 7M Q3 '25: 7M Q4 '25: 7.5M Q1 '26: 7.7M Q2 '26: 8M Q3 '26: 8.8M Q4 '26: 9.3M Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25 Q4 '26

Gross Profit TTM

-24M -16M -8M 0 8M 16M 24M Q4 '20: -12.8M Q1 '21: -14M Q2 '21: -15.4M Q3 '21: -15.5M Q4 '21: -15.9M Q1 '22: -15.6M Q2 '22: -15.3M Q3 '22: -17M Q4 '22: -17.3M Q1 '23: -18.8M Q2 '23: -20.6M Q3 '23: -21.6M Q4 '23: -22.5M Q1 '24: -23.2M Q2 '24: -22.2M Q3 '24: -22.4M Q4 '24: -22.3M Q1 '25: -21.7M Q2 '25: -22.6M Q3 '25: -21.4M Q4 '25: -20.8M Q1 '26: -21.6M Q2 '26: -21.2M Q3 '26: -22.5M Q4 '26: -21.6M Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24 Q4 '25 Q4 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-15M -10M -5M 0 5M 10M 15M Q1 '15: -9.2M Q2 '15: -11.2M Q3 '15: -13.2M Q4 '15: -13.2M Q1 '16: -12.4M Q2 '16: -11.2M Q3 '16: -10.2M Q4 '16: -10.3M Q1 '17: -9.9M Q2 '17: -7.9M Q3 '17: -7M Q4 '17: -6.8M Q1 '18: -4.9M Q2 '18: -4.5M Q3 '18: -3.1M Q4 '18: -1.4M Q1 '19: -255K Q2 '19: 90K Q3 '19: -213K Q4 '19: 270K Q1 '20: -825K Q2 '20: -809K Q3 '20: -6K Q4 '20: -1.9M Q1 '21: -1.3M Q2 '21: -1.6M Q3 '21: -1M Q4 '22: 607K Q1 '23: 498K Q2 '23: 242K Q3 '23: -3M Q4 '23: -5.3M Q1 '24: -7.5M Q2 '24: -9.5M Q3 '24: -9.6M Q4 '24: -7.4M Q1 '25: -3.5M Q2 '25: -787K Q3 '25: 6.3M Q4 '26: -1.1M Q1 '16 Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '23 Q3 '24 Q4 '26

Net Income TTM

-15M -10M -5M 0 5M 10M 15M Q1 '15: -8.7M Q2 '15: -9.5M Q3 '15: -11.7M Q4 '15: -13.1M Q1 '16: -12.5M Q2 '16: -12M Q3 '16: -11.6M Q4 '16: -10.4M Q1 '17: -10.1M Q2 '17: -8M Q3 '17: -7M Q4 '17: -6.9M Q1 '18: -5M Q2 '18: -4.6M Q3 '18: -3.3M Q4 '18: -1.5M Q1 '19: -319K Q2 '19: 42K Q3 '19: -251K Q4 '19: 128K Q1 '20: -996K Q2 '20: -956K Q3 '20: -512K Q4 '20: -2.4M Q1 '21: -1.7M Q2 '21: -2M Q3 '21: -1.1M Q4 '22: 548K Q1 '23: 401K Q2 '23: 108K Q3 '23: -3.1M Q4 '23: -5.3M Q1 '24: -7.6M Q2 '24: -9.6M Q3 '24: -9.7M Q4 '24: -7.3M Q1 '25: -3.4M Q2 '25: -598K Q3 '25: 6.4M Q4 '26: -1.1M Q1 '16 Q2 '17 Q3 '18 Q4 '19 Q1 '21 Q2 '23 Q3 '24 Q4 '26

Cost of Revenue TTM

0 15M 30M 45M Q4 '20: 17M Q1 '21: 18.6M Q2 '21: 20.3M Q3 '21: 20.6M Q4 '21: 21.4M Q1 '22: 21.5M Q2 '22: 21.5M Q3 '22: 23.3M Q4 '22: 23.6M Q1 '23: 25.3M Q2 '23: 27.1M Q3 '23: 28.4M Q4 '23: 29.5M Q1 '24: 30.2M Q2 '24: 29.3M Q3 '24: 29.5M Q4 '24: 29.4M Q1 '25: 28.8M Q2 '25: 29.6M Q3 '25: 28.4M Q4 '25: 28.4M Q1 '26: 29.3M Q2 '26: 29.1M Q3 '26: 31.4M Q4 '26: 30.9M Q4 '20 Q4 '21 Q4 '22 Q4 '23 Q4 '24 Q4 '25 Q4 '26

Operating Cash Flow TTM

-9M -6M -3M 0 3M 6M 9M Q1 '17: -6.3M Q2 '17: -3.6M Q3 '17: -3.6M Q4 '17: -2.8M Q1 '18: -2.3M Q2 '18: -2.2M Q3 '18: -1.1M Q4 '18: -1.2M Q1 '19: 1.1M Q2 '19: 854K Q3 '19: 1.6M Q4 '19: 1.9M Q1 '20: 1.2M Q2 '20: 1.5M Q3 '20: 612K Q4 '20: 2.9M Q1 '21: 2.5M Q2 '21: 3M Q3 '21: 2.8M Q4 '21: -1.7M Q1 '22: -750K Q2 '22: -401K Q3 '22: 3.7M Q4 '22: 6.5M Q1 '23: 6.1M Q2 '23: 8.1M Q3 '23: 5.5M Q4 '23: 4M Q1 '24: 176K Q2 '24: -2.5M Q3 '24: -5M Q4 '24: -6.1M Q1 '25: -1.8M Q2 '25: -2.7M Q3 '25: -1.3M Q4 '25: 7.4M Q1 '26: 7.7M Q2 '26: 6.2M Q3 '26: 4.4M Q4 '26: -4.5M Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25 Q4 '26

Free Cash Flow TTM

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q1 '17: -6.6M Q2 '17: -3.9M Q3 '17: -3.9M Q4 '17: -3.6M Q1 '18: -4M Q2 '18: -3.9M Q3 '18: -2.7M Q4 '18: -2.5M Q1 '19: 528K Q2 '19: 81K Q3 '19: 714K Q4 '19: 1M Q1 '20: -125K Q2 '20: 673K Q3 '20: -222K Q4 '20: 685K Q1 '21: 280K Q2 '21: 66K Q3 '21: -1.1M Q4 '21: -5M Q1 '22: -4.2M Q2 '22: -3.9M Q3 '22: 989K Q4 '22: 4.1M Q1 '23: 3.9M Q2 '23: 5.9M Q3 '23: 2.8M Q4 '23: 1.1M Q1 '24: -2.6M Q2 '24: -4.8M Q3 '24: -6.6M Q4 '24: -7M Q1 '25: -2M Q2 '25: -2.9M Q3 '25: -1.4M Q4 '25: 7M Q1 '26: 7.2M Q2 '26: 5.6M Q3 '26: 3.8M Q4 '26: -5M Q1 '18 Q2 '19 Q3 '20 Q4 '21 Q1 '23 Q2 '24 Q3 '25 Q4 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 25M 50M 75M Q2 '14: 66.9M Q3 '14: 66.9M Q1 '15: 5.8M Q2 '15: 5.7M Q3 '15: 5.6M Q1 '16: 8.7M Q2 '16: 8.7M Q3 '16: 8.7M Q1 '17: 9.8M Q2 '17: 11M Q3 '17: 11M Q1 '18: 11M Q2 '18: 11M Q3 '18: 11M Q1 '19: 12.6M Q2 '19: 14M Q3 '19: 11.5M Q1 '20: 11.6M Q2 '20: 13M Q3 '20: 13.7M Q1 '21: 14.2M Q2 '21: 15.1M Q3 '21: 14.5M Q1 '22: 13.4M Q2 '22: 14.5M Q3 '22: 14.4M Q1 '23: 13.5M Q2 '23: 13.5M Q3 '23: 13.6M Q1 '24: 13.5M Q2 '24: 13.5M Q3 '24: 13.6M Q1 '25: 14M Q2 '25: 14M Q3 '25: 14.4M Q1 '26: 13.8M Q2 '26: 14.5M Q3 '26: 13.9M Q1 '15 Q3 '16 Q2 '18 Q1 '20 Q3 '21 Q2 '23 Q1 '25 Q3 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.40 -1.60 -0.80 0.00 0.80 1.60 2.40 Q1 '14: -0.12 Q2 '14: -0.11 Q3 '14: -0.11 Q4 '14: -0.11 Q1 '15: -0.72 Q2 '15: -1.34 Q3 '15: -1.93 Q4 '15: -2.16 Q1 '16: -1.85 Q2 '16: -1.49 Q3 '16: -1.16 Q4 '16: -1.20 Q1 '17: -1.13 Q2 '17: -0.89 Q3 '17: -0.74 Q4 '17: -0.64 Q1 '18: -0.44 Q2 '18: -0.40 Q3 '18: -0.28 Q4 '18: -0.13 Q1 '19: -0.03 Q2 '19: -0.00 Q3 '19: -0.02 Q4 '19: 0.01 Q1 '20: -0.09 Q2 '20: -0.09 Q3 '21: -0.11 Q4 '22: 0.04 Q1 '23: 0.03 Q2 '23: 0.01 Q3 '23: -0.22 Q4 '23: -0.39 Q1 '24: -0.56 Q2 '24: -0.71 Q3 '24: -0.72 Q4 '24: -0.54 Q1 '25: -0.26 Q2 '25: -0.06 Q3 '25: 0.44 Q4 '26: -0.07 Q1 '15 Q2 '16 Q3 '17 Q4 '18 Q1 '20 Q2 '23 Q3 '24 Q4 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.